One tablet a month? Breakthrough could reinvent drugs

One tablet a month? Breakthrough could reinvent drugs

Table of Contents

One tablet a month? Breakthrough could reinvent drugs
A brand new drug supply platform is designed to ship a number of days’ value of medicine in a single dose.

Think about a world the place you may toss out your each day tablet field and easily take a single tablet that will ship every week or month’s value of medication.

A world the place you would not have to fret in case your family members remembered to take their tablets every day; the place as an alternative, adhering to drugs was a once-a-week or once-a-month proposition.

The excellent news is that science may be very shut to creating long-acting oral tablets a actuality, because of a brand new, breakthrough drug supply platform designed to ship a number of days’ value of medication in a single dose.

For 2-thirds (66%) of People, prescribed drugs – notably each day tablets – are vital to keep up their well being. But taking these tablets – usually at totally different instances all through the day – will be tough for each sufferers and caregivers who help these they love with following medical directions. In reality, a survey of greater than 1,600 adults discovered that as much as 60% of sufferers and caregivers mentioned they battle with adherence (taking tablets as prescribed).

Each day compliance will be particularly difficult for folks taking a number of medicines and people with neurological or psychological well being situations that trigger them to overlook to take their medicines.

“We all know that 9 out of 10 sufferers choose oral tablets to different types of medicine supply, however long-acting tablets have not been attainable for many medicines – till now,” mentioned Wealthy Scranton M.D., M.P.H., chief medical officer at Lyndra Therapeutics. Lyndra’s LYNX drug supply platform has the potential for broad applicability throughout a number of oral therapies – together with authorised medication and people at the moment in improvement.”

The LYNX platform is designed to ship long-acting therapies inside a standard-sized oral capsule. The capsule contains drug-containing “arms” which might be designed to ship drugs steadily for the specified dosing interval.

In a current survey carried out by Lyndra, 80% of sufferers mentioned they discovered the idea of an oral weekly tablet interesting as a result of its means to simplify their lives and make taking medicines simpler to recollect, mentioned Scranton. “By changing each day tablets with long-acting oral therapies which might be designed to ship as much as a month’s value of medication, the LYNX platform has the potential to enhance medicine adherence, positively impacting the danger of relapse, hospitalization and different damaging well being penalties.”

Lyndra’s LYNX platform is being studied in a number of therapeutic areas. Pivotal scientific trials for the LYNX platform with risperidone in folks dwelling with schizophrenia are deliberate to provoke inside the subsequent quarter. Part 1 trials investigating the LYNX platform for ivermectin (to assist in malaria eradication) not too long ago started, and extra research are deliberate for the close to future for opioid use dysfunction, girls’s well being and cardiometabolic drugs.

“Lyndra’s LYNX drug supply platform is designed to remodel the affected person expertise,” mentioned Scranton. “We’re deeply dedicated to bringing the LYNX platform to sufferers, releasing them from the burden of each day tablets and simplifying their lives.”

For extra details about how long-acting oral therapies have the potential to reinvent drugs, go to